In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer

被引:44
作者
Fodero-Tavoletti, Michelle T. [1 ,2 ]
Brockschnieder, Damian [3 ]
Villemagne, Victor L. [4 ,5 ,6 ]
Martin, Lucas [3 ]
Connor, Andrea R. [1 ,2 ]
Thiele, Andrea [3 ]
Berndt, Mathias [3 ]
McLean, Catriona A. [7 ]
Krause, Sabine [3 ]
Rowe, Christopher C. [4 ,5 ]
Masters, Colin L. [6 ]
Dinkelborg, Ludger [3 ]
Dyrks, Thomas [3 ]
Cappai, Roberto [1 ,2 ]
机构
[1] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Mol & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia
[3] Global Drug Discovery, Bayer HealthCare Pharmaceut, Berlin, Germany
[4] Austin Hlth, Dept Nucl Med, Melbourne, Vic 3084, Australia
[5] Austin Hlth, Ctr PET, Melbourne, Vic 3084, Australia
[6] Mental Hlth Res Inst, Parkville, Vic 3052, Australia
[7] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic 3181, Australia
基金
英国医学研究理事会;
关键词
A beta; Imaging; Alzheimer's disease; Dementia; PET; PRECLINICAL ALZHEIMERS-DISEASE; POSITRON-EMISSION-TOMOGRAPHY; PITTSBURGH COMPOUND-B; AMYLOID-BETA; LEWY BODIES; PET; DEMENTIA; PLAQUES; BRAIN; CONSORTIUM;
D O I
10.1016/j.nucmedbio.2012.03.001
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Amyloid-beta (A beta) plagues are a major pathological hallmark of Alzheimer's disease (AD). The noninvasive detection of A beta plagues may increase the accuracy of clinical diagnosis as well as monitor therapeutic interventions. While [C-11]-PiB is the most widely used A beta positron emission tomography (PET) radiotracer, due to the short half-life of C-11 (20 min), its application is limited to centers with an on-site cyclotron and C-11 radiochemistry expertise. Therefore, novel [F-18] (half-life 110 min)-labeled A beta PET tracers have been developed. We have demonstrated that [F-18]-florbetaben-PET can differentiate individuals diagnosed with AD from healthy elderly, Parkinson's disease and frontotemporal lobe dementia (FTLD-tau) patients. While [F-18]-florbetaben-PET retention matched the reported postmortem distribution of A beta plagues, the nature of [F-18]-florbetaben binding to other pathological lesions comprising misfolded proteins needs further assessment. The objective of this study was to determine whether Florbetaben selectively binds to A beta plagues in postmortem tissue specimens containing mixed pathological hallmarks (i.e., tau and alpha-synuclein aggregates). Method: Human AD, FTLD-tau and dementia with Lewy bodies (DLB) brain sections were analyzed by [F-18]-florbetaben autoradiography and [H-3]-florbetaben high-resolution emulsion autoradiography and [F-19]-florbetaben fluorescence microscopy. Results: Both autoradiographical analyses demonstrated that Florbetaben exclusively bound A beta plagues in AD brain sections at low nanomolar concentrations. Furthermore, at concentrations thousand-folds higher than those during a PET scan, [F-19]-florbetaben did not bind to alpha-synuclein or tau aggregates in DLB and FTLD-tau brain sections, respectively. Detection of [F-19]-florbetaben staining by fluorescence microscopy in several AD brain regions demonstrated that Florbetaben identified A beta plaques in all brain regions examined. Conclusion: This study provides further evidence that [F-18]-florbetaben-PET is a highly selective radiotracer to assess A beta plague deposition in the brain. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1042 / 1048
页数:7
相关论文
共 35 条
[21]   Imaging β-amyloid burden in aging and dementia [J].
Rowe, C. C. ;
Ng, S. ;
Ackermann, U. ;
Gong, S. J. ;
Pike, K. ;
Savage, G. ;
Cowie, T. F. ;
Dickinson, K. L. ;
Maruff, P. ;
Darby, D. ;
Smith, C. ;
Woodward, M. ;
Merory, J. ;
Tochon-Danguy, H. ;
O'Keefe, G. ;
Klunk, W. E. ;
Mathis, C. A. ;
Price, J. C. ;
Masters, C. L. ;
Villemagne, V. L. .
NEUROLOGY, 2007, 68 (20) :1718-1725
[22]  
Rowe CC, 2010, NEUROBIOL AGING
[23]   Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer:: proof of mechanism [J].
Rowe, Christopher C. ;
Ackerman, Uwe ;
Browne, William ;
Mulligan, Rachel ;
Pike, Kerryn L. ;
O'Keefe, Graeme ;
Tochon-Danguy, Henty ;
Chan, Gordon ;
Berlangieri, Salvatore U. ;
Jones, Gareth ;
Dickinson-Rowe, Kerryn L. ;
Kung, Hank P. ;
Zhang, Wei ;
Kung, Mei Ping ;
Skovronsky, Daniel ;
Dyrks, Thomas ;
Hall, Gerhard ;
Krause, Sabine ;
Friebe, Matthias ;
Lehman, Lutz ;
Lindemann, Stefanie ;
Dinkelborg, Ludger M. ;
Masters, Colin L. ;
Villemagne, Victor L. .
LANCET NEUROLOGY, 2008, 7 (02) :129-135
[24]   Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease [J].
Shoghi-Jadid, K ;
Small, GW ;
Agdeppa, ED ;
Kepe, V ;
Ercoli, LM ;
Siddarth, P ;
Read, S ;
Satyamurthy, N ;
Petric, A ;
Huang, SC ;
Barrio, JR .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 10 (01) :24-35
[25]   Generation of a recombinant Fab antibody reactive with the Alzheimer's disease-related Aβ peptide [J].
Tammer, AH ;
Coia, G ;
Cappai, R ;
Fuller, S ;
Masters, CL ;
Hudson, P ;
Underwood, JR .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 129 (03) :453-463
[26]  
Thal Dietmar R, 2006, Sci Aging Knowledge Environ, V2006, pre1, DOI 10.1126/sageke.2006.6.re1
[27]   Phases of Aβ-deposition in the human brain and its relevance for the development of AD [J].
Thal, DR ;
Rüb, U ;
Orantes, M ;
Braak, H .
NEUROLOGY, 2002, 58 (12) :1791-1800
[28]   Emerging Alzheimer's disease therapies: focusing on the future [J].
Trojanowski, JQ .
NEUROBIOLOGY OF AGING, 2002, 23 (06) :985-990
[29]   18F-Flutemetamol Amyloid Imaging in Alzheimer Disease and Mild Cognitive Impairment A Phase 2 Trial [J].
Vandenberghe, Rik ;
Van Laere, Koen ;
Ivanoiu, Adrian ;
Salmon, Eric ;
Bastin, Christine ;
Triau, Eric ;
Hasselbalch, Steen ;
Law, Ian ;
Andersen, Allan ;
Korner, Alex ;
Minthon, Lennart ;
Garraux, Gaetan ;
Nelissen, Natalie ;
Bormans, Guy ;
Buckley, Chris ;
Owenius, Rikard ;
Thurfjell, Lennart ;
Farrar, Gill ;
Brooks, David J. .
ANNALS OF NEUROLOGY, 2010, 68 (03) :319-329
[30]   Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease [J].
Villemagne, V. L. ;
Pike, K. E. ;
Darby, D. ;
Maruff, P. ;
Savage, G. ;
Ng, S. ;
Ackermann, U. ;
Cowie, T. F. ;
Currie, J. ;
Chan, S. G. ;
Jones, G. ;
Tochon-Danguy, H. ;
O'Keefe, G. ;
Masters, C. L. ;
Rowe, C. C. .
NEUROPSYCHOLOGIA, 2008, 46 (06) :1688-1697